-
System Biosciences Announces License of ExoQuick® Technology to QIAGEN
PRESS RELEASE: System Biosciences (SBI), a leading provider of exosome research tools and services, Continue reading → -
What’s new in exosome research? Here are a few of the recent papers we’re most excited about
A roundup of the recent exosome literature highlights the therapeutic potential of stem cell-derived exosomes and the complex role of exosomes in cancer. Continue reading →